Researcher Michal Schwartz: ‘We will soon be able to boost those immune cells that are most relevant to the brain.’

OncoHost’s prediction platform is geared to help physicians choose the best chemo or immunotherapy for each patient, rather than the hit and miss 'one size fits all.'